Therefore, we investigated the expression levels of neurexin-1β, neuroligin-1, synapsin, and PSD95 because these indicators of synaptic structure have previously been used to evaluate neuroplasticity in other models of AD. The gene discussed is NLGN1; the disease is Alzheimer disease.